{
  "id": "histopathology",
  "title": "Histopathology",
  "lang": "en",
  "source_lang": "en",
  "summary": "Histopathology examines diseased tissues microscopically to identify disease, classify tumors, assess tissue injury, and inform clinical management.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Histological pathology",
    "Tissue pathology"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/histopathology/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/histopathology/",
      "json": "https://aiwiki.page/zh/histopathology.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Histopathology is the study and microscopic examination of diseased tissues. A branch of pathology, it connects alterations in cells and tissue architecture with the causes, mechanisms, and clinical manifestations of disease. Its principal materials are tissue specimens obtained by biopsy, surgical removal, or autopsy. Unlike tests that measure substances in blood or other fluids, histopathology preserves spatial relationships: it shows which cells are abnormal, how they are organized, and how they interact with surrounding structures.\n\nHistopathology is central to the diagnosis and classification of many diseases, particularly cancer, but also inflammatory, infectious, metabolic, and inherited disorders. Examination may establish whether a lesion is benign or malignant, document organ injury, identify microorganisms, or determine whether a tumor has reached a surgical margin. Modern practice combines conventional microscopy with antibody-based stains, molecular testing, and digital imaging. Interpretation depends not only on the appearance of a slide but also on specimen quality, clinical information, imaging findings, and knowledge of how disease changes over time."
    },
    {
      "heading": "Scope and historical development",
      "text": "Histopathology applies the methods of histology, the study of normal tissue structure, to disease. Its distinctive strength is the simultaneous examination of individual cells and their architectural context. A collection of atypical cells may have different implications depending on whether it remains within a gland, penetrates the surrounding connective tissue, or occupies a blood vessel. These relationships often cannot be reconstructed from isolated cells alone. Cytopathology, which examines exfoliated or aspirated cells and small cell groups, is therefore closely related but not identical.\n\nThe discipline emerged from a gradual shift in the anatomical explanation of disease. In 1761, Giovanni Battista Morgagni published De sedibus et causis morborum per anatomen indagatis, relating clinical illnesses to abnormalities found in organs after death. Around the beginning of the nineteenth century, Marie François Xavier Bichat emphasized tissues as fundamental components of organs, largely through anatomical observation rather than microscopy. These approaches displaced explanations that treated disease primarily as a disturbance of bodily fluids without a localized structural basis.\n\nImproved microscopes and the development of cell theory made cellular explanations possible. Rudolf Virchow’s 1858 work Cellularpathologie helped establish the principle that disease should be understood through alterations in cells. During the nineteenth and early twentieth centuries, advances in fixation, paraffin embedding, microtomy, and staining turned tissue microscopy into a reproducible laboratory practice. These techniques allowed thin, durable sections to be prepared, compared, stored, and re-examined rather than viewed only as fresh fragments.\n\nThe twentieth century extended observation beyond routine light microscopy. Electron microscopy revealed cellular ultrastructure; immunofluorescence localized antibodies and other molecules in tissues; and immunohistochemistry identified cellular proteins while preserving morphology. Antigen-retrieval methods introduced into routine practice in the 1990s substantially expanded the usefulness of antibody stains on formalin-fixed material. Molecular methods subsequently allowed genetic alterations to be examined alongside tissue appearance.\n\nThe professional scope of histopathology varies among health systems. In some countries, the specialty includes surgical pathology, autopsy pathology, and aspects of cytopathology; elsewhere, these are organized as separate services within anatomical pathology. Subspecialization commonly follows organ systems, including gastrointestinal, breast, skin, renal, and neuropathology. Despite these administrative differences, the central activity is consistent: establishing a defensible interpretation of tissue changes through morphological examination supported by appropriate ancillary tests."
    },
    {
      "heading": "Specimen acquisition, fixation, and tissue processing",
      "text": "The diagnostic process begins before tissue reaches the microscope. A specimen must represent the lesion, retain sufficient structure, and be linked unambiguously to the patient and anatomical site. Needle cores, endoscopic biopsies, skin punches, curettings, and large surgical resections differ greatly in the amount of information they provide. A small core may establish tumor type but cannot necessarily show the full extent of invasion or the relationship to surgical margins. Sampling an ulcerated or necrotic center may produce less useful tissue than sampling viable portions of a lesion.\n\nAt receipt, specimens are accessioned, identified, and examined macroscopically. During this “gross examination,” the pathologist or trained practitioner records dimensions, appearance, anatomical relationships, and relevant lesions. Resections may be oriented using sutures or other markers supplied by the surgeon. Colored inks identify external surfaces and margins so that their relationship to disease can later be recognized microscopically. Representative pieces are placed in labeled cassettes; very small biopsies may be submitted in their entirety.\n\nMost routine tissue is preserved in 10% neutral buffered formalin, which contains approximately 4% formaldehyde. Fixation limits enzymatic self-digestion and microbial decomposition and stabilizes tissue largely through chemical modification and cross-linking of proteins. It is not instantaneous: tissue thickness, fixative access, temperature, and elapsed time all affect preservation. Delayed fixation can cause autolysis and alter detectable proteins or nucleic acids, whereas prolonged fixation can interfere with some ancillary assays. Requirements are therefore assay- and specimen-specific rather than governed by a single universal fixation interval.\n\nAfter fixation, routine processing removes water through graded alcohols, replaces the alcohol with a clearing agent, and infiltrates the tissue with molten paraffin wax. The resulting block provides support for cutting sections, commonly about 3–5 micrometers thick, using a microtome. Sections are transferred to glass slides, dried, deparaffinized, and stained. The paraffin block remains an important archive: additional levels, antibody stains, or molecular tests may be performed later if sufficient tissue remains.\n\nSome specimens require different pathways. Mineralized bone may need decalcification, but strong acid treatment can damage nucleic acids and compromise certain stains. Suspected lymphoma may require fresh tissue for flow cytometry, while renal biopsies are often divided for light microscopy, immunofluorescence, and electron microscopy. Tissue intended for microbiological culture must be handled separately from formalin-fixed material. Allocation is especially important with tiny specimens, because placing all available tissue into one preservative can make other investigations impossible."
    },
    {
      "heading": "Staining, microscopy, and recognition of tissue patterns",
      "text": "The standard stain in most histopathology laboratories is hematoxylin and eosin, commonly abbreviated H&E. Hematoxylin, used with a mordant, highlights nuclei and other nucleic-acid-rich structures in blue to purple. Eosin colors many cytoplasmic and extracellular proteins in shades of pink. Together they reveal nuclear detail, cell boundaries, connective tissue, blood vessels, and the arrangement of glands or other structures. Their broad informational value explains why H&E remains the starting point even when sophisticated molecular tests are available.\n\nExamination usually moves between magnifications. At low power, the observer assesses the overall distribution of a lesion, its interface with normal tissue, and patterns such as nodules, sheets, glands, or diffuse infiltration. Higher power reveals chromatin, nucleoli, cytoplasmic contents, mitoses, and small organisms. A large nucleus or prominent nucleolus is not inherently malignant: activated immune cells and regenerating epithelium may show both. Interpretation depends on combinations of features and their architectural setting.\n\nA central task is distinguishing reversible stress, cell death, repair, and abnormal growth. Tissue injury may produce cellular swelling, fat accumulation, loss of normal differentiation, or necrosis. Apoptosis typically affects individual cells through a regulated process associated with cell shrinkage and fragmentation. These appearances are not wholly specific to a cause. Ischemia, toxins, infection, and immune injury can generate overlapping patterns, while the timing of sampling affects which stage is visible.\n\nInflammatory patterns provide another interpretive framework. Neutrophil-rich inflammation often accompanies acute tissue injury or bacterial infection, whereas lymphocytes and plasma cells are prominent in many chronic inflammatory conditions. Eosinophils may occur in allergic, parasitic, drug-associated, and other reactions. A granuloma is an organized aggregation of macrophages, often with epithelioid appearance and multinucleated giant cells. Granulomas narrow the diagnostic possibilities but do not by themselves establish a particular infection or immune disorder.\n\nSpecial stains emphasize constituents poorly distinguished on H&E. Periodic acid–Schiff staining highlights certain carbohydrates, basement membranes, and many fungi; silver stains can demonstrate fungal walls or fine supporting fibers; trichrome stains distinguish collagen from other tissue components. Congo red supports the identification of amyloid deposition through characteristic staining and birefringence under polarized light. Acid-fast stains can demonstrate mycobacteria, although a negative stain does not exclude infection. Each stain answers a defined question and must be interpreted with controls, morphology, and clinical findings rather than as an isolated positive or negative result."
    },
    {
      "heading": "Immunohistochemistry, ultrastructure, and molecular testing",
      "text": "Immunohistochemistry uses antibodies to localize antigens within tissue sections. In a common method, an antibody binds its target and a detection system produces a colored deposit visible by light microscopy. This adds molecular identity to morphology: a pathologist can determine not merely whether a protein is present, but which cells express it and whether staining is nuclear, membranous, or cytoplasmic. Heat- or enzyme-based antigen retrieval can improve detection of targets masked during fixation.\n\nAntibody panels help establish cellular lineage and distinguish diseases with similar appearances. Broad-spectrum cytokeratins support epithelial differentiation; selected lymphoid markers characterize B- or T-cell populations; and other markers support melanocytic, muscular, or neuroendocrine differentiation. None of these categories is perfectly captured by a single stain. Aberrant expression, weak staining, background signal, and antigen loss can mislead, so the diagnostic value lies in the combined pattern rather than the number of positive markers. Internal tissue elements and external control sections help establish whether a stain has worked as intended.\n\nImmunohistochemistry also measures clinically relevant biomarkers. In breast cancer, estrogen receptor, progesterone receptor, and HER2 testing contribute to tumor characterization and treatment selection. Mismatch-repair protein staining can identify loss of particular repair proteins in tumors and contribute to assessment for Lynch syndrome. Such loss does not by itself establish an inherited disorder: sporadic mechanisms can produce similar findings. Predictive assays use defined scoring systems and validation requirements because thresholds and staining patterns may have direct clinical consequences.\n\nImmunofluorescence uses fluorescent labels rather than a permanent colored deposit. It is especially important in renal pathology and some blistering skin diseases, where the distribution of immunoglobulins and complement helps distinguish mechanisms of injury. Electron microscopy provides a different scale of evidence, revealing features such as basement-membrane alterations, immune-type deposits, and abnormalities of specialized cellular structures. Its use is selective, but in some renal and inherited disorders ultrastructure remains diagnostically important.\n\nMolecular tests examine DNA, RNA, or chromosomal alterations in tissue. In situ hybridization preserves spatial localization, whereas extracted material can be analyzed by polymerase chain reaction or sequencing. These methods can detect gene rearrangements, mutations, amplification, or viral nucleic acids. Their performance depends on tumor content, fixation, nucleic-acid quality, and assay sensitivity. A histopathologist may mark a tumor-rich area for enrichment before extraction. Molecular findings and morphology are interpreted together: a genetic alteration may define a diagnostic category in one setting but have a different significance in another."
    },
    {
      "heading": "Tumor diagnosis, grading, staging, and predictive assessment",
      "text": "In tumor pathology, the first questions concern whether a lesion is neoplastic, which lineage it represents, and whether it is benign, intermediate, or malignant. A neoplasm is an abnormal proliferation whose classification depends on tissue of origin, differentiation, architecture, and sometimes defining molecular alterations. Reactive proliferations can imitate tumors, while some malignant tumors appear deceptively bland. Consequently, malignancy cannot be reduced to a single feature such as nuclear size, rapid growth, or a high mitotic count.\n\nThe distinction between noninvasive and invasive epithelial disease is particularly important. Carcinoma in situ remains confined to the epithelial compartment without established invasion through the basement membrane into supporting tissue. Invasive carcinoma has crossed that boundary. Assessment can be difficult when orientation is poor, tissue is fragmented, or inflammation obscures the interface. Additional sections and selected immunostains may clarify the relationship, but the limitations of the specimen remain relevant.\n\nTumor grade describes biological features assessed within a defined tumor type; it is not interchangeable with stage. Grading systems may incorporate differentiation, mitotic activity, nuclear features, or necrosis. The Nottingham system for invasive breast carcinoma combines tubule formation, nuclear pleomorphism, and mitotic count. Grading of prostate cancer emphasizes glandular architecture through Gleason patterns and associated Grade Groups. These systems have different criteria and should not be treated as a universal scale applicable to all cancers.\n\nStage describes anatomical extent. The TNM system classifies many solid tumors through the primary tumor, regional lymph nodes, and distant metastases, although detailed rules differ by site. Pathological staging uses evidence from removed tissue and is distinguished from staging based principally on clinical examination and imaging. A resection report may document tumor size, depth of invasion, involved nodes, lymphovascular invasion, and the relationship to adjacent structures. Some cancers use other staging frameworks, and not every stage component can be determined from a single specimen.\n\nMargin assessment evaluates whether tumor reaches a designated resection surface or how close it lies to that surface. Its meaning depends on tumor type, anatomical site, specimen orientation, and the surgical procedure. A negative sampled margin does not guarantee that every possible residual tumor focus has been excluded. Similarly, a negative lymph node result applies to the examined nodes and methods used. After systemic therapy or radiation therapy, histopathology may assess viable residual tumor, treatment-related fibrosis, and nodal response. These measurements contribute to prognosis and multidisciplinary interpretation but are not substitutes for the complete clinical record."
    },
    {
      "heading": "Non-neoplastic disease and organ-specific interpretation",
      "text": "Histopathology is equally concerned with diseases that do not involve tumors. In inflammatory disorders, the distribution and composition of tissue injury may distinguish broad mechanisms even when a single cause cannot be identified. In inflammatory bowel disease, biopsies are assessed for architectural distortion, chronic inflammatory expansion, neutrophil activity, and other changes. The pattern across different intestinal sites, together with endoscopic and clinical findings, helps distinguish disease categories. Infection, medication effects, and ischemia can produce overlapping appearances.\n\nRenal pathology illustrates how several techniques combine to explain organ dysfunction. Light microscopy identifies patterns such as glomerular hypercellularity, segmental scarring, crescents, or interstitial inflammation. Immunofluorescence shows the composition and distribution of deposited immune reactants, while electron microscopy localizes deposits and reveals ultrastructural injury. In lupus nephritis, classification reflects the distribution and character of renal lesions. Assessments of active inflammation and chronic scarring capture different dimensions of injury; extensive established damage may coexist with ongoing active disease.\n\nIn liver tissue, histopathology distinguishes patterns of hepatocellular injury, bile-duct injury, cholestasis, fat accumulation, and fibrosis. Fibrosis represents extracellular-matrix accumulation following repeated or sustained injury, while cirrhosis involves diffuse architectural remodeling with fibrous septa and regenerative nodules. Histological patterns can support particular causes, but several disorders converge on similar late-stage appearances. Because a needle biopsy samples only a small fraction of the liver, the distribution of fibrosis and other lesions introduces sampling variability.\n\nFor infectious diseases, tissue examination may demonstrate organisms directly or show the host response around them. Fungal forms, parasites, viral inclusions, and bacterial colonies can sometimes be recognized microscopically. Species-level identification may nevertheless require culture, antigen testing, or molecular methods. In tuberculosis, necrotizing granulomatous inflammation is a useful pattern but is not specific, and organisms may be sparse. In immunocompromised patients, severe infection may occur with surprisingly little inflammation, showing that the tissue response depends on host immunity as well as the pathogen.\n\nBiopsies from transplanted organs are assessed for rejection, infection, drug-associated injury, recurrent disease, and other complications. Standardized organ-specific frameworks help describe lesions, but interpretation still requires timing, organ function, drug exposure, and laboratory findings. Similar principles apply to skin, muscle, lung, and nervous-system biopsies: the same morphological change may have several causes, and diagnostic confidence increases when the sampled lesion, disease stage, and clinical question are well matched."
    },
    {
      "heading": "Intraoperative examination and pathology reporting",
      "text": "Some tissue questions arise while an operation is still in progress. Frozen-section examination provides a rapid microscopic assessment by freezing fresh tissue, cutting it in a cryostat, and applying a quick stain. Common uses include identifying a sampled lesion, assessing selected margins, or determining whether a specimen contains tissue needed for further investigation. The clinical question is usually narrower than that of the final report because time and tissue quality constrain the examination.\n\nFreezing introduces artifacts, especially in fatty, watery, or delicate tissues. Ice crystals distort cells, and rapid sections generally show less detail than well-prepared paraffin sections. Some diagnoses require extensive sampling, special stains, or demonstration of invasion at a scale that cannot be reliably assessed intraoperatively. The pathologist may therefore provide a limited answer or defer diagnosis until permanent sections are available. A frozen-section result is a time-sensitive interpretation of sampled material, not a guarantee that the final classification will be identical.\n\nThe final histopathology report translates observations into a clinically usable record. Depending on the specimen, it includes the tissue source, diagnosis, relevant microscopic findings, and necessary qualifiers. Cancer resection reports often use structured or synoptic formats so that tumor type, grade, size, invasion, margins, and lymph node findings are recorded consistently. Protocols developed by organizations such as the College of American Pathologists and the International Collaboration on Cancer Reporting support completeness and standardized terminology, while allowing for differences between tumor sites and specimen types.\n\nClinical context is essential to interpretation. Age, anatomical location, prior malignancy, relevant medications, imaging findings, and earlier biopsy results may change the meaning of an otherwise similar microscopic pattern. Comparison with a previous tumor can help distinguish a new primary lesion from metastatic disease. Discussion in multidisciplinary meetings allows pathological findings to be reconciled with radiology, operative observations, and other investigations. A tissue diagnosis that does not explain the observed lesion may require reassessment of sampling or interpretation rather than automatic acceptance as conclusive.\n\nReports also communicate uncertainty. Terms such as “consistent with,” “suspicious for,” or “cannot exclude” convey different degrees of confidence, although their practical interpretation can vary. Clear reporting identifies the source of uncertainty, such as scant tissue, treatment effects, or an unresolved differential diagnosis. An addendum commonly records subsequently available ancillary results; an amended report documents correction or revision of previously issued findings. Maintaining a traceable record matters because pathology reports may inform decisions long after the original specimen was examined."
    },
    {
      "heading": "Quality assurance, artifacts, and diagnostic limitations",
      "text": "Reliable histopathology requires control of the entire chain from specimen collection to reporting. Identification errors, incorrect site labeling, delayed transport, inadequate fixation, and loss of small tissue fragments can compromise diagnosis before interpretation begins. Laboratory safeguards include documented specimen acceptance procedures, unique identifiers, tracking systems, and checks at transfer points. These measures are part of patient safety because even a technically excellent slide is harmful if attributed to the wrong patient or anatomical site.\n\nPreparation artifacts can mimic disease or obscure important structures. Crushing may distort small lymphoid cells; electrocautery produces thermal damage near surgical edges; tissue folds create apparent thickening; and sectioning chatter creates alternating bands of compression. Tiny fragments carried from another specimen can appear as unexpected tissue “floaters.” Recognition depends on the relationship between the suspicious finding and the rest of the specimen, comparison with additional sections, and review of the processing history when necessary.\n\nSampling places a fundamental limit on accuracy. A section is a two-dimensional plane through a three-dimensional structure, and only selected areas of many large specimens are embedded. A small biopsy can miss a focal lesion or fail to represent the most diagnostically important region. Deeper sections may reveal a structure absent from the first level, but they cannot recover tissue that was never sampled. Likewise, absence of organisms or malignant cells in the examined material is not equivalent to proof that they are absent everywhere in the patient.\n\nInterpretive variability is another limitation. Some categories have sharp morphological boundaries, while others lie along biological continua or rely on features that observers may weight differently. Borderline epithelial lesions, grading systems, and some inflammatory patterns can show interobserver disagreement. Clear criteria, specialist review, multidisciplinary correlation, and validated ancillary tests improve consistency but do not eliminate uncertainty. Histopathology often serves as a reference standard in diagnostic studies, yet it remains subject to measurement error, sampling error, and changes in classification.\n\nQuality assurance includes equipment maintenance, stain controls, assay validation, proficiency testing, selected second reviews, and monitoring of discrepancies and reporting times. A laboratory may use accreditation frameworks such as ISO 15189 to structure its quality system. Validation must fit the intended use: showing that an antibody produces visible staining is different from demonstrating that a particular scoring method reliably supports a clinical decision. When discrepancies are identified, distinguishing collection, processing, interpretation, and communication failures helps reveal where corrective action is needed."
    },
    {
      "heading": "Digital pathology, computation, and research uses",
      "text": "Digital pathology converts glass slides into images that can be viewed, shared, and analyzed electronically. Whole-slide scanners capture many adjacent fields and assemble them into a navigable representation of the tissue section. This supports remote consultation, teaching, archival access, and workflows in which pathologists interpret cases on validated displays. The image is still a representation of a prepared section: scanning cannot repair poor fixation, recover unsampled tissue, or automatically resolve an ambiguous diagnosis.\n\nClinical implementation requires validation of the complete system, including scanner performance, focus, image completeness, display conditions, software, and user workflow. Large slide files create substantial storage and network demands, and not all microscopic information is equally easy to capture. Routine scanning usually records a single focal plane, whereas some preparations require examination through multiple depths. Laboratories also need procedures for scanner failure, incomplete scans, and situations in which glass-slide review remains necessary.\n\nComputational image analysis quantifies features such as cell counts, stained area, nuclear characteristics, or spatial relationships between cell populations. Machine-learning systems can be trained to detect tumor, identify regions requiring review, or estimate biomarker expression. Performance depends on the quality and representativeness of training data, the reliability of annotations, and the clinical task being evaluated. A model that performs well on one collection may perform differently when staining, scanners, patient populations, or disease prevalence change.\n\nEvaluation therefore requires more than accuracy on a convenient image set. Relevant questions include performance on independent material, the consequences of false-positive and false-negative findings, and how pathologists behave when using the system. Predictions of molecular abnormalities from routine images are an active research area, but statistical association does not necessarily provide a clinically adequate replacement for a validated molecular assay. Governance also involves data privacy, cybersecurity, version control, and the traceability of algorithm-generated outputs.\n\nHistopathology has a broader research role through tissue archives, experimental studies, and clinical trials. Archived paraffin blocks allow investigators to relate morphology and molecular features to later outcomes, although retrospective collections can contain selection bias and variable preservation. In trials, centralized pathology review can standardize eligibility, confirm diagnoses, and assess tissue-based endpoints. Multiplex imaging and spatial molecular methods increasingly combine cell identity, molecular activity, and anatomical position, extending the traditional histopathological question of what is present to include how neighboring cells and tissue compartments are organized."
    }
  ],
  "links": [
    "pathology",
    "biopsy",
    "diagnosis",
    "cancer",
    "histology",
    "bone",
    "hematoxylin-and-eosin-stain",
    "necrosis",
    "apoptosis",
    "inflammation",
    "immunohistochemistry",
    "biomarker",
    "breast-cancer",
    "lynch-syndrome",
    "dna",
    "prostate-cancer",
    "metastasis",
    "radiation-therapy",
    "inflammatory-bowel-disease",
    "lupus-nephritis",
    "fibrosis",
    "cirrhosis",
    "infectious-disease",
    "tuberculosis",
    "organ-transplantation",
    "patient-safety",
    "digital-pathology",
    "machine-learning",
    "training-data",
    "data-privacy",
    "clinical-trial"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}